TrialThe Journal of infectious diseases2016

Immunogenicity and Safety of an AS03-Adjuvanted H7N9 Pandemic Influenza Vaccine in a Randomized Trial in Healthy Adults.

Anuradha Madan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.